Log In
Print
BCIQ
Print
Print this Print this
 

Epzicom, Kivexa (abacavir/lamivudine)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral fixed-dose combination of nucleoside reverse transcriptase inhibitors (NRTIs) lamivudine and abacavir
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Latest Stage of DevelopmentMarketed
IndicationHIV / AIDS
Partner

Pfizer Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today